Evidence map›Paper›PMID 31464511›Full record

Trial reportJournal of child and adolescent psychopharmacology2020

A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across Settings.

Ann C Childress, Andrew J Cutler, Andrea Marraffino, Mary Ann McDonnell, John M Turnbow, Matthew Brams, Norberto J DeSousa, Bev Incledon, Floyd R Sallee, Sharon B Wigal

Abstract readClinical Trial, Phase IIIMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of child and adolescent psychopharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ann C ChildressCenter for Psychiatry and Behavioral Medicine, Inc., Las Vegas, Nevada.
Andrew J CutlerMeridien Research, Bradenton, Florida.
Andrea MarraffinoMeridien Research, Maitland, Florida.
Mary Ann McDonnellSouth Shore Psychiatric Services, Hingham, Massachusetts.
John M TurnbowWestex Clinical Investigations, Lubbock, Texas.
Matthew BramsBayou City Research, Ltd., Houston, Texas.
Norberto J DeSousaIronshore Pharmaceuticals & Development, Inc., Camana Bay, Grand Cayman, Cayman Islands.
Bev IncledonIronshore Pharmaceuticals & Development, Inc., Camana Bay, Grand Cayman, Cayman Islands.
Floyd R SalleeIronshore Pharmaceuticals Inc., Durham, North Carolina.
Sharon B WigalAVIDA, Inc., Newport Beach, California.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Attention Deficit Disorder with HyperactivityCentral Nervous System StimulantsChildDelayed-Action PreparationsDouble-Blind MethodFemaleHumansMalePsychiatric Status Rating ScalesCentral Nervous System StimulantsDelayed-Action Preparationsattention-deficit/hyperactivity disorderDR/ER-MPHdurationfunctional impairmentmethylphenidatesafety

Identifiers

PMID31464511
PMCPMC7041320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.